PatientsVille.com Logo

Somatropin Side Effects

PatientsVille

Common Somatropin Side Effects


The most commonly reported Somatropin side effects (click to view or check a box to report):

Craniopharyngioma (59)
Death (54)
Pituitary Tumour Benign (45)
Neoplasm Recurrence (43)
Condition Aggravated (42)
Sleep Apnoea Syndrome (41)
Adenoidal Hypertrophy (33)
Meningioma (29)
Tonsillar Hypertrophy (28)
Headache (27)
Prostate Cancer (23)
Dyspnoea (22)
Germ Cell Cancer (20)
Fall (20)
Scoliosis (19)
Vomiting (18)
Convulsion (18)
Pneumonia (18)
Disease Progression (17)
Osteochondrosis (16)

➢ More



If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Somatropin Side Effects Reported to FDA



Somatropin Side Effect Report#8439420-7
Medulloblastoma Recurrent
This is a report of a 22-year-old male patient (weight: NA) from Netherlands, suffering from the following health symptoms/conditions: hypopituitarism, who was treated with Somatropin (dosage: 0.2 Mg, 1x/day, start time:
Aug 27, 2009), combined with: NA. and developed a serious reaction and side effect(s): Medulloblastoma Recurrent after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Somatropin treatment in male patients, resulting in Medulloblastoma Recurrent side effect. The patient was hospitalized and became disabled.
Somatropin Side Effect Report#8433772-X
Nephrotic Syndrome
This report suggests a potential Somatropin Nephrotic Syndrome side effect(s) that can have serious consequences. A 6-year-old female patient (weight: NA) from Japan was diagnosed with the following symptoms/conditions: small for dates baby and used Somatropin (dosage: 0.4 Mg, 1x/day) starting
Dec 15, 2010. After starting Somatropin the patient began experiencing various side effects, including: Nephrotic SyndromeAdditional drugs used concurrently: NA.The patient was hospitalized. Although Somatropin demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Nephrotic Syndrome, may still occur.
Somatropin Side Effect Report#8429022-0
Craniopharyngioma, Neoplasm Recurrence
This Craniopharyngioma problem was reported by a physician from Japan. A 11-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: NA. On
Jan 22, 2009 this consumer started treatment with Somatropin (dosage: 0.8 Mg, 1x/day). The following drugs were being taken at the same time: NA. When using Somatropin, the patient experienced the following unwanted symptoms/side effects: Craniopharyngioma, Neoplasm RecurrenceThe patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Craniopharyngioma, may become evident only after a product is in use by the general population.
Somatropin Side Effect Report#8421603-3
Medulloblastoma Recurrent
This Medulloblastoma Recurrent side effect was reported by a physician from Netherlands. A 22-year-old male patient (weight:NA) experienced the following symptoms/conditions: hypopituitarism.The patient was prescribed Somatropin (drug dosage: 0.2 Mg, 1x/day), which was initiated on
Aug 27, 2009. Concurrently used drugs: NA..After starting to take Somatropin the consumer reported adverse symptoms, such as: Medulloblastoma RecurrentThese side effects may potentially be related to Somatropin. The patient was hospitalized and became disabled.
Somatropin Side Effect Report#8407386-1
Hypoacusis
This is a report of a male patient (weight: NA) from United States, suffering from the following health symptoms/conditions: growth retardation, who was treated with Somatropin (dosage: NA, start time:
Feb 09, 2010), combined with:
  • Flintstones Vitamins
and developed a serious reaction and side effect(s): Hypoacusis after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Somatropin treatment in male patients, resulting in Hypoacusis side effect.
Somatropin Side Effect Report#8397226-1
Intestinal Ischaemia
This report suggests a potential Somatropin Intestinal Ischaemia side effect(s) that can have serious consequences. A male patient (weight: NA) from United Kingdom was diagnosed with the following symptoms/conditions: growth hormone deficiency,blood thyroid stimulating hormone decreased,primary hypothyroidism,blood corticotrophin decreased,hypopituitarism and used Somatropin (dosage: 0.2 Mg, 1x/day 7 Injections Per Week) starting
Apr 11, 2002. After starting Somatropin the patient began experiencing various side effects, including: Intestinal IschaemiaAdditional drugs used concurrently:
  • Levothyroxine Sodium (100 Ug, Daily)
  • Levothyroxine Sodium
  • Hydrocortisone (30 Mg, Daily)
The patient was hospitalized. Although Somatropin demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Intestinal Ischaemia, may still occur.
Somatropin Side Effect Report#8396082-5
Calcification Metastatic
This Calcification Metastatic problem was reported by a health professional from United States. A female patient (weight: NA) was diagnosed with the following symptoms/conditions: renal failure. On
Aug 10, 2010 this consumer started treatment with Somatropin (dosage: NA). The following drugs were being taken at the same time:
  • Poly-vi-sol
  • Zantac
  • Sensipar
  • Amlodipine Besylate
  • Calcium Carbonate (Route G Tube)
  • Benadryl
When using Somatropin, the patient experienced the following unwanted symptoms/side effects: Calcification MetastaticAlthough all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Calcification Metastatic, may become evident only after a product is in use by the general population.
Somatropin Side Effect Report#8395287-7
No Adverse Event
This No Adverse Event side effect was reported by a physician from Japan. A 5-year-old female patient (weight:NA) experienced the following symptoms/conditions: small for dates baby.The patient was prescribed Somatropin (drug dosage: 0.5 Mg, 1x/day), which was initiated on
Feb 18, 2010. Concurrently used drugs: NA..After starting to take Somatropin the consumer reported adverse symptoms, such as: No Adverse EventThese side effects may potentially be related to Somatropin.
Somatropin Side Effect Report#8395286-5
Neoplasm Recurrence, Craniopharyngioma
This is a report of a 11-year-old male patient (weight: NA) from Japan, suffering from the following health symptoms/conditions: NA, who was treated with Somatropin (dosage: 0.8 Mg, 1x/day, start time:
Jul 16, 2009), combined with:
  • Gonadotropin Chorionic (900 Iu, Monthly)
and developed a serious reaction and side effect(s): Neoplasm Recurrence, Craniopharyngioma after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Somatropin treatment in male patients, resulting in Neoplasm Recurrence side effect. The patient was hospitalized.
Somatropin Side Effect Report#8386666-2
Peritonitis
This report suggests a potential Somatropin Peritonitis side effect(s) that can have serious consequences. A 54-year-old male patient (weight: NA) from France was diagnosed with the following symptoms/conditions: NA and used Somatropin (dosage: 0.8 Mg, 1x/day) starting
Jan 01, 2001. After starting Somatropin the patient began experiencing various side effects, including: PeritonitisAdditional drugs used concurrently:
  • Hydrocortisone (Unk)
  • Alprazolam (Unk)
  • Testosterone (Unk)
  • Levothyroxine Sodium (Unk)
Although Somatropin demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Peritonitis, may still occur.
Somatropin Side Effect Report#8386480-8
Syncope, Asthenia, Fall
This Syncope problem was reported by a health professional from Ireland. A 15-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: NA. On
Apr 18, 2012 this consumer started treatment with Somatropin Rdna (dosage: (1.1 Mg Subcutaneous). The following drugs were being taken at the same time: NA. When using Somatropin Rdna, the patient experienced the following unwanted symptoms/side effects: Syncope, Asthenia, FallAlthough all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Syncope, may become evident only after a product is in use by the general population.
Somatropin Side Effect Report#8369775-3
Osteochondrosis
This Osteochondrosis side effect was reported by a physician from Japan. A 7-year-old female patient (weight:NA) experienced the following symptoms/conditions: body height below normal,growth hormone deficiency.The patient was prescribed Somatropin (drug dosage: 2.7 Mg, Weekly), which was initiated on
Oct 27, 2008. Concurrently used drugs: NA..After starting to take Somatropin the consumer reported adverse symptoms, such as: OsteochondrosisThese side effects may potentially be related to Somatropin.
Somatropin Side Effect Report#8366600-1
Osteochondrosis
This is a report of a 7-year-old female patient (weight: NA) from Japan, suffering from the following health symptoms/conditions: NA, who was treated with Somatropin (dosage: 3.3 Mg, Weekly, start time:
Oct 27, 2008), combined with: NA. and developed a serious reaction and side effect(s): Osteochondrosis after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Somatropin treatment in female patients, resulting in Osteochondrosis side effect.
Somatropin Side Effect Report#8363211-9
Meningioma, Neoplasm Recurrence
This report suggests a potential Somatropin Meningioma side effect(s) that can have serious consequences. A 23-year-old male patient (weight: NA) from France was diagnosed with the following symptoms/conditions: NA and used Somatropin (dosage: Unk) starting
Sep 02, 2002. After starting Somatropin the patient began experiencing various side effects, including: Meningioma, Neoplasm RecurrenceAdditional drugs used concurrently: NA. Although Somatropin demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Meningioma, may still occur.
Somatropin Side Effect Report#8352409-1
Brain Oedema
This Brain Oedema problem was reported by a physician from Netherlands. A 4-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: growth hormone deficiency. On
Feb 23, 2001 this consumer started treatment with Somatropin (dosage: Unk). The following drugs were being taken at the same time: NA. When using Somatropin, the patient experienced the following unwanted symptoms/side effects: Brain OedemaAlthough all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Brain Oedema, may become evident only after a product is in use by the general population.
Somatropin Side Effect Report#8352404-2
Brain Neoplasm
This Brain Neoplasm side effect was reported by a physician from France. A 17-year-old male patient (weight:NA) experienced the following symptoms/conditions: NA.The patient was prescribed Somatropin (drug dosage: 2 Mg, 1x/day), which was initiated on
Aug 05, 2003. Concurrently used drugs: NA..After starting to take Somatropin the consumer reported adverse symptoms, such as: Brain NeoplasmThese side effects may potentially be related to Somatropin.
Somatropin Side Effect Report#8350825-5
Acromegaly
This is a report of a 40-year-old male patient (weight: NA) from Netherlands, suffering from the following health symptoms/conditions: NA, who was treated with Somatropin (dosage: Unk, start time: NS), combined with: NA. and developed a serious reaction and side effect(s): Acromegaly after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Somatropin treatment in male patients, resulting in Acromegaly side effect.
Somatropin Side Effect Report#8345105-8
Colon Cancer, Gastrointestinal Haemorrhage
This report suggests a potential Somatropin Colon Cancer side effect(s) that can have serious consequences. A male patient (weight: NA) from United States was diagnosed with the following symptoms/conditions: hypopituitarism and used Somatropin (dosage: 0.6 Mg, Qd) starting
May 20, 2002. After starting Somatropin the patient began experiencing various side effects, including: Colon Cancer, Gastrointestinal HaemorrhageAdditional drugs used concurrently:
  • Deltacortril (Unk)
  • Testosterone Cypionate (Unk)
  • Spiriva (Unk)
  • Advair Diskus 100/50 (Unk)
  • Vytorin (Unk)
  • Aspirin (Unk)
  • Singulair (Unk)
  • Plavix (Unk)
The patient was hospitalized. Although Somatropin demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Colon Cancer, may still occur.
Somatropin Side Effect Report#8342957-2
Brain Neoplasm
This Brain Neoplasm problem was reported by a physician from France. A 17-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: NA. On
Aug 05, 2003 this consumer started treatment with Somatropin (dosage: 2 Mg, 1x/day). The following drugs were being taken at the same time: NA. When using Somatropin, the patient experienced the following unwanted symptoms/side effects: Brain NeoplasmAlthough all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Brain Neoplasm, may become evident only after a product is in use by the general population.
Somatropin Side Effect Report#8341540-2
Fall, Syncope, Asthenia
This Fall side effect was reported by a health professional from Ireland. A 15-year-old male patient (weight:NA) experienced the following symptoms/conditions: NA.The patient was prescribed Somatropin Rdna (drug dosage: (1.1 Mg Subcutaneous)), which was initiated on
Apr 18, 2012. Concurrently used drugs: NA..After starting to take Somatropin Rdna the consumer reported adverse symptoms, such as: Fall, Syncope, AstheniaThese side effects may potentially be related to Somatropin Rdna.
Somatropin Side Effect Report#8334709-4
Pituitary Tumour Benign
This is a report of a 50-year-old female patient (weight: NA) from Sweden, suffering from the following health symptoms/conditions: NA, who was treated with Somatropin (dosage: 0.2 Mg, 1x/day, start time:
Apr 08, 2009), combined with:
  • Minirin (Unk)
  • Bromocriptine Mesylate (Unk)
  • Bromocriptine Mesylate (Unk)
  • Folic Acid (Unk)
and developed a serious reaction and side effect(s): Pituitary Tumour Benign after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Somatropin treatment in female patients, resulting in Pituitary Tumour Benign side effect.
Somatropin Side Effect Report#8334340-0
Convulsion, Liver Injury, Product Quality Issue, Blood Glucose Decreased
This report suggests a potential Somatropin Convulsion side effect(s) that can have serious consequences. A 4-year-old female patient (weight: NA) from United States was diagnosed with the following symptoms/conditions: hypopituitarism and used Somatropin (dosage: NA) starting NS. After starting Somatropin the patient began experiencing various side effects, including: Convulsion, Liver Injury, Product Quality Issue, Blood Glucose DecreasedAdditional drugs used concurrently: NA.The patient was hospitalized. Although Somatropin demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Convulsion, may still occur.
Somatropin Side Effect Report#8334077
Craniopharyngioma
This Craniopharyngioma problem was reported by a physician from FR. A 35-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: growth hormone deficiency. On
Jul 20, 2011 this consumer started treatment with Somatropin (dosage: NA). The following drugs were being taken at the same time: NA. When using Somatropin, the patient experienced the following unwanted symptoms/side effects: CraniopharyngiomaThe patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Craniopharyngioma, may become evident only after a product is in use by the general population.
Somatropin Side Effect Report#8330171-6
Pituitary Tumour Benign
This Pituitary Tumour Benign side effect was reported by a physician from Sweden. A 50-year-old female patient (weight:NA) experienced the following symptoms/conditions: NA.The patient was prescribed Somatropin (drug dosage: 0.4 Mg, 1x/day), which was initiated on
Nov 14, 2006. Concurrently used drugs: NA..After starting to take Somatropin the consumer reported adverse symptoms, such as: Pituitary Tumour BenignThese side effects may potentially be related to Somatropin.
Somatropin Side Effect Report#8329422-3
Medulloblastoma
This is a report of a 12-year-old male patient (weight: NA) from Spain, suffering from the following health symptoms/conditions: hypopituitarism, who was treated with Somatropin Rdna (dosage: Concentration: 10 Mg/2 Ml, start time:
Oct 07, 2011), combined with: NA. and developed a serious reaction and side effect(s): Medulloblastoma after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Somatropin Rdna treatment in male patients, resulting in Medulloblastoma side effect.


  7 of 58 


The appearance of Somatropin on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.

What are common Somatropin Side Effects for Men?

Men Side EffectsReports
Craniopharyngioma 38
Death 30
Neoplasm Recurrence 26
Pituitary Tumour Benign 25
Prostate Cancer 20
Adenoidal Hypertrophy 19
Condition Aggravated 19
Dyspnoea 18
Meningioma 17
Fall 13

Track Your Side Effects

Note Your Observations

It is really important to keep track of your health symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

Why Your Notes are Important

Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:
    Side Effects Scale Date & Time Other Medicine(s) or Treatment(s)
    Scale: 1 = very mild to 10 = very bad

    Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

    Somatropin reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
    FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.

    Discuss Somatropin Side Effects

    Did You Have a Somatropin Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor
    No

    How Effective is Somatropin for You?

    Exceeded Expectations
    Effective
    Somewhat Effective
    Not Effective

    Somatropin Safety Alerts, Active Ingredients, Usage Information

    More About Somatropin

    Side Effects reported to FDA: 1445

    Somatropin safety alerts: 2010 2003 2002 2001

    Reported deaths: 118

    Reported hospitalizations: 665

    Latest Somatropin clinical trials